About Nagi Bioscience
Nagi Bioscience is a company based in Lausanne (Switzerland) founded in 2017 by Matteo Cornaglia. Nagi Bioscience has raised $1.84 million across 2 funding rounds from investors including Zurcher Kantonalbank, Nest Sammelstiftung and Verve Ventures. Nagi Bioscience offers products and services including SydLab™ One, Contract Laboratory Solutions, and Organism-on-Chip Technology. Nagi Bioscience operates in a competitive market with competitors including Biocytogen, Applied StemCell, Interius Biotherapeutics, GemPharmatech and Business Catalyst, among others.
- Headquarter Lausanne, Switzerland
- Founders Matteo Cornaglia
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nagi Bioscience Sa
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.84 M (USD)
in 2 rounds
-
Latest Funding Round
$1.84 M (USD), Seed
Dec 20, 2019
-
Investors
Zurcher Kantonalbank
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nagi Bioscience
Nagi Bioscience offers a comprehensive portfolio of products and services, including SydLab™ One, Contract Laboratory Solutions, and Organism-on-Chip Technology.
Automated high-content platform for drug testing using C. elegans nematodes.
End-to-end solutions for aging, toxicity, and neurodegenerative studies.
Innovative system for ethical testing of chemicals and drugs.
People of Nagi Bioscience
Unlock access to complete
Unlock access to complete
Funding Insights of Nagi Bioscience
Nagi Bioscience has successfully raised a total of $1.84M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.84 million completed in December 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Nagi Bioscience
Nagi Bioscience has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Zurcher Kantonalbank, Nest Sammelstiftung and Verve Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on science and tech-driven startups
|
Locked | Locked | Locked | |
|
Early-stage entrepreneurs are accelerated through MassChallenge's program.
|
Locked | Locked | Locked | |
|
Commercial banking services are provided across Switzerland by Zurcher Kantonalbank.
|
Locked | Locked | Locked |
Investor details for Nagi Bioscience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nagi Bioscience
Investment portfolio details for Nagi Bioscience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nagi Bioscience
Detailed financials for Nagi Bioscience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nagi Bioscience Comparisons
Peer comparison for Nagi Bioscience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nagi Bioscience
Nagi Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biocytogen, Applied StemCell, Interius Biotherapeutics, GemPharmatech and Business Catalyst, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Integrated solutions for next-generation antibody drug development are provided.
|
|
| Locked | Locked | Locked |
Provider of animal and cell line models as tools for drug discovery and diagnostics
|
|
| Locked | Locked | Locked |
Developer of gene therapies for treating multiple diseases
|
|
| Locked | Locked | Locked |
Humanized models and drug screening technologies are developed for research.
|
|
| Locked | Locked | Locked |
In-vivo mouse models are developed for biomedical R&D applications.
|
Detailed competitors of Nagi Bioscience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nagi Bioscience
Complete news archive for Nagi Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nagi Bioscience
Nagi Bioscience was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Nagi Bioscience is headquartered in Lausanne, Switzerland. It is registered at Lausanne, Vaud, Switzerland.
Matteo Cornaglia is the current CEO of Nagi Bioscience. They have also founded this company.
Nagi Bioscience is a funded company, having raised a total of $1.84M across 2 funding rounds to date.
Nagi Bioscience was founded in 2017 in Lausanne, Switzerland, within the biotechnology sector. An organism-on-a-chip platform is utilized, based on the nematode Caenorhabditis elegans, to enable in vivo assessments. Applications include drug discovery processes, toxicity evaluations, and screening of compounds for efficacy against parasitic worm infections. Operations focus on providing these testing services to support pharmaceutical and research needs.
Nagi Bioscience's top competitors include Biocytogen, Applied StemCell and GemPharmatech.
Nagi Bioscience offers SydLab™ One, Contract Laboratory Solutions, and Organism-on-Chip Technology.
Nagi Bioscience has 4 investors. Key investors include Zurcher Kantonalbank, Nest Sammelstiftung, Verve Ventures, and MassChallenge.